Predicting PTSD: Pre-existing vulnerabilities in glucocorticoid-signaling and implications for preventive interventions

Brain, Behavior, and Immunity

Volumn 30, Issue , 2013, Pages 12-21

  van Zuiden, Mirjam ^a   Kavelaars, Annemieke ^b,c   Geuze, Elbert ^d,e   Olff, Miranda ^a,f   Heijnen, Cobi J ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^d Ministerie van Defensie   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f ARQ PSYCHOTRAUMA EXPERT GROUP   (Netherlands)

Author keywords

Biomarker; FKBP5; Glucocorticoid; PTSD; Trauma; Vulnerability

Indexed keywords

ARGIPRESSIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HYDROCORTISONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MIFEPRISTONE; OXYTOCIN; PLACEBO; TRANSCRIPTION FACTOR AP 1;

ALLELE; ANXIETY DISORDER; BINDING AFFINITY; CHEMOPROPHYLAXIS; COGNITION; DEPRESSION; DISEASE COURSE; DRUG EFFICACY; DRUG MEGADOSE; GENETIC TRANSCRIPTION; HIPPOCAMPUS; HUMAN; MONONUCLEAR CELL; MOOD DISORDER; NEGATIVE FEEDBACK; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHOSIS; REVIEW; SECONDARY PREVENTION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SOCIAL INTERACTION;

GLUCOCORTICOIDS; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, GLUCOCORTICOID; RISK FACTORS; SIGNAL TRANSDUCTION; STRESS DISORDERS, POST-TRAUMATIC; TACROLIMUS BINDING PROTEINS;

EID: 84876867628     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2012.08.015     Document Type: Review

References (106)

1. Aardal-Eriksson E., Eriksson T.E., Thorell L.H. Salivary cortisol, posttraumatic stress symptoms, and general health in the acute phase and during 9-month follow-up. Biol. Psychiatry. 2001, 50:986-993.
2. Admon, R., Lubin, G., Rosenblatt, J.D., Stern, O., Kahn, I., Assaf, M., Hendler, T., 2012. Imbalanced neural responsivity to risk and reward indicates stress vulnerability in humans. Cereb. Cortex, in press [Epub ahead of print].
3. Agorastos A., Marmar C.R., Otte C. Immediate and early behavioral interventions for the prevention of acute and posttraumatic stress disorder. Curr. Opin. Psychiatry. 2011, 24:526-532.
4. American Psychiatric Association, 2000. Diagnostic and Statistical Manual of Mental Disorders (fourth ed., text revision). Author, Washington, DC.
5. Armanini D., Spinella P., Simoncini M., Basso A., Zovato S., Pozzan G.B., De Palo C.B., Bucciante G., Karbowiak I. Regulation of corticosteroid receptors in patients with anorexia nervosa and Cushing's syndrome. J. Endocrinol. 1998, 158:435-439.
6. Ayroldi E., Riccardi C. Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action. FASEB J. 2009, 23:3649-3658.
7. Bachmann A.W., Sedgley T.L., Jackson R.V., Gibson J.N., Young R.M., Torpy D.J. Glucocorticoid receptor polymorphisms and post-traumatic stress disorder. Psychoneuroendocrinology 2005, 30:297-306.
8. Binder E.B., Bradley R.G., Liu W., Epstein M.P., Deveau T.C., Mercer K.B., Tang Y., Gillespie C.F., Heim C.M., Nemeroff C.B., Schwartz A.C., Cubells J.F., Ressler K.J. Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 2008, 299:1291-1305.
9. Bonne O., Brandes D., Segman R., Pitman R.K., Yehuda R., Shalev A.Y. Prospective evaluation of plasma cortisol in recent trauma survivors with posttraumatic stress disorder. Psychiatry Res. 2003, 119:171-175.
10. Boscarino J.A. Psychobiologic predictors of disease mortality after psychological trauma: implications for research and clinical surveillance. J. Nerv. Ment. Dis. 2008, 196:100-107.
11. Boscarino J.A., Erlich P.M., Hoffman S.N., Rukstalis M., Stewart W.F. Association of FKBP5, COMT and CHRNA5 polymorphisms with PTSD among outpatients at risk for PTSD. Psychiatry Res. 2011, 188:173-174.
12. Boscarino J.A., Erlich P.M., Hoffman S.N., Zhang X. Higher FKBP5, COMT, CHRNA5, and CRHR1 allele burdens are associated with PTSD and interact with trauma exposure: implications for neuropsychiatric research and treatment. Neuropsychiatr. Dis. Treat. 2012, 8:131-139.
13. Brewin C.R., Andrews B., Valentine J.D. Meta-analysis of risk factors for posttraumatic stress disorder in trauma-exposed adults. J. Consult. Clin. Psychol. 2000, 68:748-766.
14. Buckingham J.C. Glucocorticoids: exemplars of multi-tasking. Br. J. Pharmacol. 2006, 147:258-268.
15. Cohen H., Kaplan Z., Kozlovsky N., Gidron Y., Matar M.A., Zohar J. Hippocampal microinfusion of oxytocin attenuates the behavioural response to stress by means of dynamic interplay with the glucocorticoid-catecholamine responses. J. Neuroendocrinol. 2010, 22:889-904.
16. Cohen H., Matar M.A., Buskila D., Kaplan Z., Zohar J. Early post-stressor intervention with high-dose corticosterone attenuates posttraumatic stress response in an animal model of posttraumatic stress disorder. Biol. Psychiatry. 2008, 64:708-717.
17. Cordero M.I., Sandi C. A role for brain glucocorticoid receptors in contextual fear conditioning: dependence upon training intensity. Brain Res. 1998, 786:11-17.
18. Davis M., Whalen P.J. The amygdala: vigilance and emotion. Mol. Psychiatry. 2001, 6:13-34.
19. De Bosscher K., Van Craenenbroeck K., Meijer O.C., Haegeman G. Selective transrepression versus transactivation mechanisms by glucocorticoid receptor modulators in stress and immune systems. Eur. J. Pharmacol. 2008, 583:290-302.
20. de Kloet C.S., Vermetten E., Bikker A., Meulman E., Geuze E., Kavelaars A., Westenberg H.G., Heijnen C.J. Leukocyte glucocorticoid receptor expression and immunoregulation in veterans with and without post-traumatic stress disorder. Mol. Psychiatry. 2007, 12:443-453.
21. de Lange P., Segeren C.M., Koper J.W., Wiemer E., Sonneveld P., Brinkmann A.O., White A., Brogan I.J., de Jong F.H., Lamberts S.W. Expression in hematological malignancies of a glucocorticoid receptor splice variant that augments glucocorticoid receptor-mediated effects in transfected cells. Cancer Res. 2001, 61:3937-3941.
22. de Rooij S.R., Costello P.M., Veenendaal M.V., Lillycrop K.A., Gluckman P.D., Hanson M.A., Painter R.C., Roseboom T.J. Associations between DNA methylation of a glucocorticoid receptor promoter and acute stress responses in a large healthy adult population are largely explained by lifestyle and educational differences. Psychoneuroendocrinology 2012, 37:782-788.
23. de Vries G.J., Olff M. The lifetime prevalence of traumatic events and posttraumatic stress disorder in the Netherlands. J. Trauma. Stress. 2009, 22:259-267.
24. Delahanty D.L. Toward the predeployment detection of risk for PTSD. Am. J. Psychiatry. 2011, 168:9-11.
25. Delahanty D.L., Nugent N.R., Christopher N.C., Walsh M. Initial urinary epinephrine and cortisol levels predict acute PTSD symptoms in child trauma victims. Psychoneuroendocrinology 2005, 30:121-128.
26. Delahanty D.L., Raimonde A.J., Spoonster E. Initial posttraumatic urinary cortisol levels predict subsequent PTSD symptoms in motor vehicle accident victims. Biol. Psychiatry. 2000, 48:940-947.
27. Delahanty D.L., Raimonde A.J., Spoonster E., Cullado M. Injury severity, prior trauma history, urinary cortisol levels, and acute PTSD in motor vehicle accident victims. J. Anxiety Disord. 2003, 17:149-164.
28. Denny W.B., Valentine D.L., Reynolds P.D., Smith D.F., Scammell J.G. Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding. Endocrinology 2000, 141:4107-4113.
29. Dudley K.J., Li X., Kobor M.S., Kippin T.E., Bredy T.W. Epigenetic mechanisms mediating vulnerability and resilience to psychiatric disorders. Neurosci. Biobehav. Rev. 2011, 35:1544-1551.
30. Ehring T., Ehlers A., Cleare A.J., Glucksman E. Do acute psychological and psychobiological responses to trauma predict subsequent symptom severities of PTSD and depression?. Psychiatry Res. 2008, 161:67-75.
31. Fletcher S., Creamer M., Forbes D. Preventing posttraumatic stress disorder: are drugs the answer?. Aust. N. Z. J. Psychiatry. 2010, 44:1064-1071.
32. Geuze E., van Wingen G.A., van Zuiden M., Rademaker A.R., Vermetten E., Kavelaars A., Fernandez G., Heijnen C.J. Glucocorticoid receptor number predicts increase in amygdala activity after severe stress. Psychoneuroendocrinology 2012, 37:1837-1844.
33. Gill J., Luckenbaugh D., Charney D., Vythilingam M. Sustained elevation of serum interleukin-6 and relative insensitivity to hydrocortisone differentiates posttraumatic stress disorder with and without depression. Biol. Psychiatry. 2010, 68:999-1006.
34. Golier J.A., Caramanica K., Demaria R., Yehuda R. A pilot study of mifepristone in combat-related PTSD. Depress Res. Treat. 2012, 2012:393251.
35. Gotovac K., Sabioncello A., Rabatíac S., Berki T., Dekaris D. Flow cytometric determination of glucocorticoid receptor (GCR) expression in lymphocyte subpopulations: lower quantity of GCR in patients with post-traumatic stress disorder (PTSD). Clin. Exp. Immunol. 2003, 131:335-339.
36. Grossman R., Yehuda R., Golier J., McEwen B., Harvey P., Maria N.S. Cognitive effects of intravenous hydrocortisone in subjects with PTSD and healthy control subjects. Ann. N.Y. Acad. Sci. 2006, 1071:410-421.
37. Hagendorf A., Koper J.W., de Jong F.H., Brinkmann A.O., Lamberts S.W., Feelders R.A. Expression of the human glucocorticoid receptor splice variants alpha, beta, and P in peripheral blood mononuclear leukocytes in healthy controls and in patients with hyper- and hypocortisolism. J. Clin. Endocrinol. Metab. 2005, 90:6237-6243.
38. Hauer D., Weis F., Papassotiropoulos A., Schmoeckel M., Beiras-Fernandez A., Lieke J., Kaufmann I., Kirchhoff F., Vogeser M., Roozendaal B., Briegel J., de Quervain D., Schelling G. Relationship of a common polymorphism of the glucocorticoid receptor gene to traumatic memories and posttraumatic stress disorder in patients after intensive care therapy. Crit. Care Med. 2011, 39:643-650.
39. Heijnen C.J. Receptor regulation in neuroendocrine-immune communication: current knowledge and future perspectives. Brain Behav. Immun. 2007, 21:1-8.
40. Heim C., Nemeroff C.B. Neurobiology of posttraumatic stress disorder. CNS Spectr. 2009, 14:13-24.
41. Heinrichs M., Wagner D., Schoch W., Soravia L.M., Hellhammer D.H., Ehlert U. Predicting posttraumatic stress symptoms from pretraumatic risk factors: a 2-year prospective follow-up study in firefighters. Am. J. Psychiatry. 2005, 162:2276-2286.
42. Hollenberg S.M., Weinberger C., Ong E.S., Cerelli G., Oro A., Lebo R., Thompson E.B., Rosenfeld M.G., Evans R.M. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 1985, 318:635-641.
43. Inslicht S.S., Otte C., McCaslin S.E., Apfel B.A., Henn-Haase C., Metzler T., Yehuda R., Neylan T.C., Marmar C.R. Cortisol awakening response prospectively predicts peritraumatic and acute stress reactions in police officers. Biol. Psychiatry. 2011, 70:1055-1062.
44. Jakovcevski M., Schachner M., Morellini F. Susceptibility to the long-term anxiogenic effects of an acute stressor is mediated by the activation of the glucocorticoid receptors. Neuropharmacology 2011, 61:1297-1305.
45. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry. 2005, 62:593-602.
46. Kino T., Su Y.A., Chrousos G.P. Human glucocorticoid receptor isoform beta: recent understanding of its potential implications in physiology and pathophysiology. Cell Mol. Life Sci. 2009, 66:3435-3448.
47. Klaassens E.R., Giltay E.J., Cuijpers P., van Veen T., Zitman F.G. Adulthood trauma and HPA-axis functioning in healthy subjects and PTSD patients: A meta-analysis. Psychoneuroendocrinology 2012, 37:317-331.
48. Koenen K.C., Saxe G., Purcell S., Smoller J.W., Bartholomew D., Miller A., Hall E., Kaplow J., Bosquet M., Moulton S., Baldwin C. Polymorphisms in FKBP5 are associated with peritraumatic dissociation in medically injured children. Mol. Psychiatry. 2005, 10:1058-1059.
49. Kohda K., Harada K., Kato K., Hoshino A., Motohashi J., Yamaji T., Morinobu S., Matsuoka N., Kato N. Glucocorticoid receptor activation is involved in producing abnormal phenotypes of single-prolonged stress rats: a putative post-traumatic stress disorder model. Neuroscience 2007, 148:22-33.
50. Kotler M., Iancu I., Efroni R., Amir M. Anger, impulsivity, social support, and suicide risk in patients with posttraumatic stress disorder. J. Nerv. Ment. Dis. 2001, 189:162-167.
51. Luca F., Kashyap S., Southard C., Zou M., Witonsky D., Di Rienzo A., Conzen S.D. Adaptive variation regulates the expression of the human SGK1 gene in response to stress. PLoS Genet. 2009, 5:e1000489.
52. Luo H., Hu X., Liu X., Ma X., Guo W., Qiu C., Wang Y., Wang Q., Zhang X., Zhang W., Hannum G., Zhang K., Liu X., Li T. Hair cortisol level as a biomarker for altered hypothalamic-pituitary-adrenal activity in female adolescents with posttraumatic stress disorder after the 2008 wenchuan earthquake. Biol. Psychiatry. 2012, 72:65-69.
53. McFarlane A.C., Atchison M., Yehuda R. The acute stress response following motor vehicle accidents and its relation to PTSD. Ann. N.Y. Acad. Sci. 1997, 821:437-441.
54. McFarlane A.C., Barton C.A., Yehuda R., Wittert G. Cortisol response to acute trauma and risk of posttraumatic stress disorder. Psychoneuroendocrinology 2011, 36:720-727.
55. Meewisse M.L., Reitsma J.B., de Vries G.J., Gersons B.P., Olff M. Cortisol and post-traumatic stress disorder in adults: systematic review and meta-analysis. Br. J. Psychiatry. 2007, 191:387-392.
56. Mehta D., Gonik M., Klengel T., Rex-Haffner M., Menke A., Rubel J., Mercer K.B., Putz B., Bradley B., Holsboer F., Ressler K.J., Muller-Myhsok B., Binder E.B. Using polymorphisms in FKBP5 to define biologically distinct subtypes of posttraumatic stress disorder: evidence from endocrine and gene expression studies. Arch. Gen. Psychiatry. 2011, 68:901-910.
57. Morris M.C., Compas B.E., Garber J. Relations among posttraumatic stress disorder, comorbid major depression, and HPA function: a systematic review and meta-analysis. Clin. Psychol. Rev. 2012, 32:301-315.
58. Mulligan K., Fear N.T., Jones N., Wessely S., Greenberg N. Psycho-educational interventions designed to prevent deployment-related psychological ill-health in Armed Forces personnel: a review. Psychol. Med. 2011, 41:673-686.
59. Munck A., Naray-Fejes-Toth A. Glucocorticoids and stress: permissive and suppressive actions. Ann. N.Y. Acad. Sci. 1994, 746:115-133.
60. Olff, M., 2012. Bonding after trauma: On the role of social support and the oxytocin system in traumatic stress, Eur. J. Psychotraumatol. 3.
61. Olff M., Langeland W., Witteveen A., Denys D. A psychobiological rationale for oxytocin in the treatment of posttraumatic stress disorder. CNS Spectr. 2010, 15:522-530.
62. Pace T.W., Heim C.M. A short review on the psychoneuroimmunology of posttraumatic stress disorder: from risk factors to medical comorbidities. Brain Behav. Immun. 2011, 25:6-13.
63. Pervanidou P., Kolaitis G., Charitaki S., Margeli A., Ferentinos S., Bakoula C., Lazaropoulou C., Papassotiriou I., Tsiantis J., Chrousos G.P. Elevated morning serum interleukin (IL)-6 or evening salivary cortisol concentrations predict posttraumatic stress disorder in children and adolescents six months after a motor vehicle accident. Psychoneuroendocrinology 2007, 32:991-999.
64. Pineles, S.L., Rasmusson, A.M., Yehuda, R., Lasko, N.B., Macklin, M.L., Pitman, R.K., Orr, S.P., 2012. Predicting emotional responses to potentially traumatic events from pre-exposure waking cortisol levels: a longitudinal study of police and firefighters. Anxiety Stress Coping, in press [Epub ahead of print].
65. Pitman R.K., Orr S.P., Lasko N.B. Effects of intranasal vasopressin and oxytocin on physiologic responding during personal combat imagery in Vietnam veterans with posttraumatic stress disorder. Psychiatry Res. 1993, 48:107-117.
66. Pratt W.B., Scherrer L.C., Hutchison K.A., Dalman F.C. A model of glucocorticoid receptor unfolding and stabilization by a heat shock protein complex. J. Steroid Biochem. Mol. Biol. 1992, 41:223-229.
67. Pruessner J.C., Wolf O.T., Hellhammer D.H., Buske-Kirschbaum A., von Auer K., Jobst S., Kaspers F., Kirschbaum C. Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocortical activity. Life Sci. 1997, 61:2539-2549.
68. Qureshi S.U., Kimbrell T., Pyne J.M., Magruder K.M., Hudson T.J., Petersen N.J., Yu H.J., Schulz P.E., Kunik M.E. Greater prevalence and incidence of dementia in older veterans with posttraumatic stress disorder. J. Am. Geriatr. Soc. 2010, 58:1627-1633.
69. Qureshi S.U., Pyne J.M., Magruder K.M., Schulz P.E., Kunik M.E. The link between post-traumatic stress disorder and physical comorbidities: a systematic review. Psychiatr. Q. 2009, 80:87-97.
70. Rao R.P., Anilkumar S., McEwen B.S., Chattarji S. Glucocorticoids Protect Against the Delayed Behavioral and Cellular Effects of Acute Stress on the Amygdala. Biol. Psychiatry 2012, 72:466-475.
71. Rauch S.L., Whalen P.J., Shin L.M., McInerney S.C., Macklin M.L., Lasko N.B., Orr S.P., Pitman R.K. Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: A functional MRI study. Biol. Psychiatry. 2000, 47:769-776.
72. Resnick H.S., Yehuda R., Pitman R.K., Foy D.W. Effect of previous trauma on acute plasma cortisol level following rape. Am. J. Psychiatry. 1995, 152:1675-1677.
73. Rhen T., Cidlowski J.A. Antiinflammatory action of glucocorticoids - new mechanisms for old drugs. N. Engl. J. Med. 2005, 353:1711-1723.
74. Roberts, N.P., Kitchiner, N.J., Kenardy, J., Bisson, J.I., 2010. Early psychological interventions to treat acute traumatic stress symptoms. Cochrane Database Syst. Rev. 3, CD007944.
75. Rohleder N., Joksimovic L., Wolf J.M., Kirschbaum C. Hypocortisolism and increased glucocorticoid sensitivity of pro-Inflammatory cytokine production in Bosnian war refugees with posttraumatic stress disorder. Biol. Psychiatry. 2004, 55:745-751.
76. Rohleder N., Wolf J.M., Wolf O.T. Glucocorticoid sensitivity of cognitive and inflammatory processes in depression and posttraumatic stress disorder. Neurosci. Biobehav. Rev. 2010, 35:104-114.
77. Sarapas C., Cai G., Bierer L.M., Golier J.A., Galea S., Ising M., Rein T., Schmeidler J., Muller-Myhsok B., Uhr M., Holsboer F., Buxbaum J.D., Yehuda R. Genetic markers for PTSD risk and resilience among survivors of the World Trade Center attacks. Dis. Markers. 2011, 30:101-110.
78. Schelling G., Briegel J., Roozendaal B., Stoll C., Rothenhausler H.B., Kapfhammer H.P. The effect of stress doses of hydrocortisone during septic shock on posttraumatic stress disorder in survivors. Biol. Psychiatry. 2001, 50:978-985.
79. Schelling G., Kilger E., Roozendaal B., de Quervain D.J., Briegel J., Dagge A., Rothenhausler H.B., Krauseneck T., Nollert G., Kapfhammer H.P. Stress doses of hydrocortisone, traumatic memories, and symptoms of posttraumatic stress disorder in patients after cardiac surgery: a randomized study. Biol. Psychiatry. 2004, 55:627-633.
80. Schelling G., Stoll C., Kapfhammer H.P., Rothenhausler H.B., Krauseneck T., Durst K., Haller M., Briegel J. The effect of stress doses of hydrocortisone during septic shock on posttraumatic stress disorder and health-related quality of life in survivors. Crit. Care Med. 1999, 27:2678-2683.
81. Segman R.H., Shefi N., Goltser-Dubner T., Friedman N., Kaminski N., Shalev A.Y. Peripheral blood mononuclear cell gene expression profiles identify emergent post-raumatic stress disorder among trauma survivors. Mol. Psychiatry. 2005, 10(500-13):425.
82. Shalev A.Y., Videlock E.J., Peleg T., Segman R., Pitman R.K., Yehuda R. Stress hormones and post-traumatic stress disorder in civilian trauma victims: a longitudinal study. art I: HPA axis responses. Int. J. Neuropsychopharmacol. 2008, 11:365-372.
83. Shin L.M., Wright C.I., Cannistraro P.A., Wedig M.M., McMullin K., Martis B., Macklin M.L., Lasko N.B., Cavanagh S.R., Krangel T.S., Orr S.P., Pitman R.K., Whalen P.J., Rauch S.L. A functional magnetic resonance imaging study of amygdala and medial prefrontal cortex responses to overtly presented fearful faces in posttraumatic stress disorder. Arch. Gen. Psychiatry. 2005, 62:273-281.
84. Steiniger B., Kniess T., Bergmann R., Pietzsch J., Wuest F.R. Radiolabeled glucocorticoids as molecular probes for imaging brain glucocorticoid receptors by means of positron emission tomography (PET). Mini-Rev. Med. Chem. 2008, 8:728-739.
85. Touma C., Gassen N.C., Herrmann L., Cheung-Flynn J., Bull D.R., Ionescu I.A., Heinzmann J.M., Knapman A., Siebertz A., Depping A.M., Hartmann J., Hausch F., Schmidt M.V., Holsboer F., Ising M., Cox M.B., Schmidt U., Rein T. FK506 binding protein 5 shapes stress responsiveness: modulation of neuroendocrine reactivity and coping behavior. Biol. Psychiatry. 2011, 70:928-936.
86. Tyrka A.R., Price L.H., Marsit C., Walters O.C., Carpenter L.L. Childhood adversity and epigenetic modulation of the leukocyte glucocorticoid receptor: preliminary findings in healthy adults. PLoS One. 2012, 7:e30148.
87. van Zuiden M., Heijnen C.J., Maas M., Amarouchi K., Vermetten E., Geuze E., Kavelaars A. Glucocorticoid sensitivity of leukocytes predicts PTSD, depressive and fatigue symptoms after military deployment: a prospective study. Psychoneuroendocrinology 2012, 37:1822-1836.
88. van Zuiden M., Geuze E., Willemen H.L., Vermetten E., Maas M., Amarouchi K., Kavelaars A., Heijnen C.J. Glucocorticoid receptor pathway components predict posttraumatic stress disorder symptom development: a prospective study. Biol. Psychiatry. 2012, 71:309-316.
89. van Zuiden M., Geuze E., Willemen H.L., Vermetten E., Maas M., Heijnen C.J., Kavelaars A. Pre-existing high glucocorticoid receptor number predicting development of posttraumatic stress symptoms after military deployment. Am. J. Psychiatry. 2011, 168:89-96.
90. van Zuiden M., Kavelaars A., Rademaker A.R., Vermetten E., Heijnen C.J., Geuze E. A prospective study on personality and the cortisol awakening response to predict posttraumatic stress symptoms in response to military deployment. J. Psychiatr. Res. 2011, 45:713-719.
91. Weaver I.C., Cervoni N., Champagne F.A., D'Alessio A.C., Sharma S., Seckl J.R., Dymov S., Szyf M., Meaney M.J. Epigenetic programming by maternal behavior. Nat. Neurosci. 2004, 7:847-854.
92. Weaver I.C.G. Epigenetic effects of glucocorticoids. Semin. Fetal Neonatal Med. 2009, 14:143-150.
93. Weis F., Kilger E., Roozendaal B., de Quervain D.J., Lamm P., Schmidt M., Schmolz M., Briegel J., Schelling G. Stress doses of hydrocortisone reduce chronic stress symptoms and improve health-related quality of life in high-risk patients after cardiac surgery: a randomized study. J. Thorac. Cardiovasc. Surg. 2006, 131:277-282.
94. Xie P., Kranzler H.R., Poling J., Stein M.B., Anton R.F., Farrer L.A., Gelernter J. Interaction of FKBP5 with childhood adversity on risk for post-traumatic stress disorder. Neuropsychopharmacology 2010, 35:1684-1692.
95. Yatzkar U., Klein E. P.3.026 Intranasal oxytocin in patients with posttraumatic stress disorder: a single dose, pilot double blind crossover study. Eur. Neuropsychopharmacol. 2010, 20:S84.
96. Yehuda R., Boisoneau D., Mason J.W., Giller E.L. Glucocorticoid receptor number and cortisol excretion in mood, anxiety, and psychotic disorders. Biol. Psychiatry. 1993, 34:18-25.
97. Yehuda R., Bierer L.M. The relevance of epigenetics to PTSD: implications for the DSM-V. J. Trauma. Stress. 2009, 22:427-434.
98. Yehuda R., Boisoneau D., Lowy M.T., Giller E.L. Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder. Arch. Gen. Psychiatry. 1995, 52:583-593.
99. Yehuda R., Cai G., Golier J.A., Sarapas C., Galea S., Ising M., Rein T., Schmeidler J., Muller-Myhsok B., Holsboer F., Buxbaum J.D. Gene expression patterns associated with posttraumatic stress disorder following exposure to the World Trade Center attacks. Biol. Psychiatry. 2009, 66:708-711.
100. Yehuda R., Golier J.A., Bierer L.M., Mikhno A., Pratchett L.C., Burton C.L., Makotkine I., Devanand D.P., Pradhaban G., Harvey P.D., Mann J.J. Hydrocortisone responsiveness in Gulf War veterans with PTSD: effects on ACTH, declarative memory hippocampal [(18)F]FDG uptake on PET. Psychiatry Res. 2010, 184:117-127.
101. Yehuda R., Halligan S.L., Grossman R., Golier J.A., Wong C. The cortisol and glucocorticoid receptor response to low dose dexamethasone administration in aging combat veterans and holocaust survivors with and without posttraumatic stress disorder. Biol. Psychiatry. 2002, 52:393-403.
102. Yehuda R., Harvey P.D., Golier J.A., Newmark R.E., Bowie C.R., Wohltmann J.J., Grossman R.A., Schmeidler J., Hazlett E.A., Buchsbaum M.S. Changes in relative glucose metabolic rate following cortisol administration in aging veterans with posttraumatic stress disorder: an FDG-PET neuroimaging study. J. Neuropsychiatry Clin. Neurosci. 2009, 21:132-143.
103. Yehuda R., Lowy M.T., Southwick S.M., Shaffer D., Giller E.L. Lymphocyte glucocorticoid receptor number in posttraumatic stress disorder. Am. J. Psychiatry. 1991, 148:499-504.
104. Yehuda R., Yang R.K., Golier J.A., Grossman R.A., Bierer L.M., Tischler L. Effect of sertraline on glucocorticoid sensitivity of mononuclear leukocytes in post-traumatic stress disorder. Neuropsychopharmacology 2006, 31:189-196.
105. Yehuda R., Golier J.A., Yang R., Tischler L. Enhanced sensitivity to glucocorticoids in peripheral mononuclear leukocytes in posttraumatic stress disorder. Biol. Psychiatry. 2004, 55:1110-1116.
106. Zohar J., Yahalom H., Kozlovsky N., Cwikel-Hamzany S., Matar M.A., Kaplan Z., Yehuda R., Cohen H. High dose hydrocortisone immediately after trauma may alter the trajectory of PTSD: interplay between clinical and animal studies. Eur. Neuropsychopharmacol. 2011, 21:796-809.